A global phase III, double-blind, randomized trial of BNT327/PM8002 plus chemotherapy (chemo) compared to atezolizumab plus chemo in patients (pts) with first-line (1L) extensive-stage small cell lung cancer (ES-SCLC).

A post on inventcures.github.io, published 30 September 2026, has not been cited by any blog yet (corpus.blog, measured 14 October 2026).

A record is what was published and who pointed at it. The text of the post is not shown here: read it at the source, or at its Wayback capture.